Literature DB >> 20028570

Tumor thrombus involving the inferior vena cava in renal malignancy: is there a difference in clinical presentation and outcome among right and left side tumors?

Devendar Katkoori1, Manoharan Murugesan, Gaetano Ciancio, Mark S Soloway.   

Abstract

PURPOSE: Renal cell carcinoma (RCC) has a propensity to propagate into the renal vein and inferior vena cava (IVC). Due to inherent differences in the venous anatomy of the right and left kidneys, tumor thrombus involvement of IVC may vary. The aim of this study is to compare clinical presentation and outcome of right vs. left RCC with IVC thrombus.
MATERIALS AND METHODS: Patients who underwent radical nephrectomy and IVC thrombectomy between 1997 and 2008 were identified. All relevant data were collected and analyzed.
RESULTS: Eight-seven patients were included. Sixty patients (69%) had a right sided tumor. Mean tumor size was 10.2 (+/- 4) cm and was not significantly different on either side. Fifty-six percent of right sided tumors had level-III (intra-hepatic) or higher tumor thrombus, while 22% of left sided tumors had similar level thrombus extension (p < 0.0001). Nearly 50% of left sided tumors showed level-I thrombus compared to 10% of right side tumors. A comparison of age, estimated blood loss and transfusion rate was not significantly different. The recurrence free (p = 0.9) and disease specific survival (p = 0.4) were not significantly different between the right and left side tumors with IVC thrombus.
CONCLUSION: A level-III IVC tumor thrombus is more frequently seen with a right side tumor. However, clinical and operative characteristics among the left and right sided tumors with IVC thrombus were not different. More significantly, recurrence rate and survival did not differ with the laterality of the tumor.

Entities:  

Mesh:

Year:  2009        PMID: 20028570     DOI: 10.1590/s1677-55382009000600003

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  5 in total

Review 1.  Prognostic Benefit of Surgical Management of Renal Cell Carcinoma Invading the Inferior Vena Cava.

Authors:  Aikaterini Mastoraki; Sotiria Mastoraki; Maria Tsikala-Vafea; Ioannis S Papanikolaou; Andreas Lazaris; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Indian J Surg Oncol       Date:  2016-05-04

2.  Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?

Authors:  David D Thiel; Christine M Lohse; Michelle L Arnold; John C Cheville; Bradley C Leibovich; Alexander S Parker
Journal:  Int Urol Nephrol       Date:  2012-04-13       Impact factor: 2.370

3.  Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee.

Authors:  Kenneth W Gow; Douglas C Barnhart; Thomas E Hamilton; Jessica J Kandel; Mike K S Chen; Fernando A Ferrer; Mitchell R Price; Elizabeth A Mullen; James I Geller; Eric J Gratias; Nancy Rosen; Geetika Khanna; Arlene Naranjo; Michael L Ritchey; Paul E Grundy; Jeffrey S Dome; Peter F Ehrlich
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

4.  Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.

Authors:  Shengjie Guo; Kai Yao; Xiaobo He; Shulin Wu; Yunlin Ye; Junxing Chen; Chin-Lee Wu
Journal:  Cancer Med       Date:  2019-08-12       Impact factor: 4.452

5.  Comprehensive managements of metastatic renal tumor with Mayo III inferior vena cava tumor thrombus: a case report.

Authors:  Chenkui Miao; Yuhao Wang; Chao Hou; Wen Chen; Aiming Xu; Zengjun Wang
Journal:  Transl Androl Urol       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.